dr reddy's glp-1 drugs portfolio 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these at scale. Our GLP-1 Drugs: For Multiple Chronic

Enriched with glutathione, vitamin C, and niacinamide, it helps even out skin tone and reduce hyperpigmentation, dark spots, and acne marks

While clinical stroke treatment obviously cannot achieve that speed, the finding demonstrates that BPC-157 neuroprotective mechanisms engage rapidly and effectively against ischemic damage

TB-500 and BPC-157 are often used together in lab research protocols examining combined or comparative tissue repair signaling

United States

Strategies to improve sleep (eg, targeting 78 hours per night) may improve male fertility markers

Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation